Retatrutide is a new medication in the fight against obesity. This novel drug, classified as a dual GLP-1 and GIP receptor agonist, exhibits promising results in research studies. By activating these receptors, https://reganoemr864493.look4blog.com/74187635/tirzepatide-a-promising-new-treatment-for-obesity